Sign in to view content

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K. Maturi, MD

Video
Published 2021

Related

Intraocular lens luxated to the vitreous cavity
Mariam Cernichiaro-Espinosa, MD
Retina Image Bank: Images of the Week
2023
Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration
David A. Eichenbaum, MD, FASRS
Updates from the Field
2018
Impact of Initial Monthly Doses of Aflibercept on Visual Outcomes in Eyes With Diabetic Macular Edema in Routine Clinical Practice in the US
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more